FACEBOOK  |  TWITTER  |  INSTAGRAM  |  LINKEDIN  |  Contact Us  |  Site Map
Get Involved

Phillip B. Maples, PhD

Phillip B. Maples, PhD
Laurus Bio
*Executive Director*

What is your current professional status?

Executive Director, Laurus Bio

What is your work setting (i.e. academic institution, government organization (i.e. FDA, NIH, etc.), bio-industry/pharmaceutical company, etc.)

Biotech Industry

What is your scientific area of research?

Cell and Gene-based Product Development, Manufacturing, Facility Design/Build, Regulatory and Clinical Affairs and Quality Systems

Why do you want to be a mentor?

As a means of developing both the quality and perception of our profession by informing younger professionals of the myriad opportunities ahead.  And they need to be scientific communicators, too!

As a mentor, what are you hoping to gain from this experience?

A sense of shared vision for the future potential and paths forward for our technical contributions in terms of patient and societal benefits, with the understanding of the daunting ethical and moral responsibilities to do the small things right (not just the big things)         

How important are the following in the selection of a mentee: (1 – 5 scale, 1 = most important, 5 = least important)

            a. Compatibility of Scientific Specialties - 2
            b. Geographic Location - 5
            c. Professional Status / Success - 3 
            d. Compatibility of Career Path - 3
            e. Communication Style - 4

Summarized in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy.

Versatile professional operating, Laurus Bio, as well as being a member of the Klyo Collaborative. 30+ years of international biotechnology.  Involved in development of pioneering cell and gene therapies including: CGD gene therapy; Autologous HBV core-specific T cells for Chronic HBV; GVAX Autologous NSCLC cell-based vaccine; Lucanix NSCLC cell-based vaccine.  Most recently at Gradalis: GNE Gene Tx for HIBM; TAG, Xenograft TAG and FANGTM Autologous Cancer Vaccines; and bifunctional RNAi therapies.  Involved in design/build or remodel of 10+ cGMP cell and gene therapy manufacturing facilities around globe; invented or co-created new manufacturing systems and processing components.  Co-created an ISO 9000 compliant quality system for a business division in Baxter Healthcare, allowing it to CE Mark and rapidly bring to market new medical devices and components.  47 publications and 9 issued U.S. patents and foreign counterparts.  Significant global experience preparing reg  ulatory submissions and developing productive collaborative international partnerships. 

Click here to view Phillip Maple's CV.